Article Text

Download PDFPDF
Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation

Footnotes

  • Competing interests: None declared.

  • Funding: The study was supported by an unrestricted grant from Hoffman-Roche and free supplies of rituximab were provided for the patients included in the study. YKOT was supported by an Agiko grant from The Netherlands Organization for Scientific Research.

  • Ethics approval: The study was approved by the Ethics Committee of the Leiden University Medical Center and all patients provided written informed consent.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests: None declared.

  • Funding: The study was supported by an unrestricted grant from Hoffman-Roche and free supplies of rituximab were provided for the patients included in the study. YKOT was supported by an Agiko grant from The Netherlands Organization for Scientific Research.

  • Ethics approval: The study was approved by the Ethics Committee of the Leiden University Medical Center and all patients provided written informed consent.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.